Johnson & Johnson Receivables 2010-2025 | JNJ

Johnson & Johnson receivables for the quarter ending March 31, 2025 were $16.020B, a 7.19% increase year-over-year.

  • Johnson & Johnson receivables for 2024 were $14.842B, a 0.21% decline from 2023.
  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.
  • Johnson & Johnson receivables for 2022 were $14.039B, a 8.14% decline from 2021.

Johnson & Johnson Receivables 2010-2025 | JNJ

  • Johnson & Johnson receivables for 2024 were $14.842B, a 0.21% decline from 2023.
  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.
  • Johnson & Johnson receivables for 2022 were $14.039B, a 8.14% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$749.3B
AbbVie (ABBV)$344.4B
Novo Nordisk (NVO)$317.1B
Roche Holding AG (RHHBY)$262.9B
Novartis AG (NVS)$261.4B
Merck (MRK)$211B
Pfizer (PFE)$146.6B
Sanofi (SNY)$121B
Bayer (BAYRY)$31.9B
Innoviva (INVA)$1.2B